March 2017March 2017
New Product - Intragam 10
Intragam 10 (human normal Immunoglobulin) is manufactured from human plasma collected by the Australian Red Cross Blood Service. Intragam 10 contains functionally intact IgG with a broad spectrum of antibodies against infectious agents. The IgG molecules have not been chemically or enzymatically modified and the Fc and Fab functions are retained. Adequate doses of human normal immunoglobulin restore abnormally low IgG levels to the normal range. Intragam 10 is indicated for replacement IgG therapy in the following conditions: primary immunodeficiency diseases; symptomatic hypogammaglobulinaemia secondary to underlying disease or treatment. Intragam 10 is indicated for immunomodulatory therapy in the following conditions: idiopathic thrombocytopenic purpura (ITP), in adults or children at high risk of bleeding or prior to surgery to correct the platelet count; Kawasaki disease; Guillain Barré syndrome (GBS); chronic inflammatory demyelinating polyneuropathy (CIDP); multifocal motor neuropathy (MMN); myasthenia gravis (MG) in acute exacerbation (myasthenic crisis) or prior to surgery and/or thymectomy; as maintenance therapy for moderate to severe MG when other treatments have been ineffective or caused intolerable side effects; short term therapy for severely affected nonparaneoplastic Lambert Eaton myasthenic syndrome (LEMS); and in the treatment of significant functional impairment in stiff person syndrome. Intragam 10 is contraindicated in patients who have had a true anaphylactic reaction to human immunoglobulins (especially in patients with antibodies against IgA) or to the excipient glycine. Intragam 10 is available as a 2.5 g/25 mL, 10 g/100 mL and 20 g/200 mL solution for infusion in vials of 1’s.
Copyright © MIMS Australia Pty Ltd. All rights reserved.
MIMS Australia
Level 2, 1 Chandos Street
St Leonards NSW 2065
Phone: 1800 800 629
info@mims.com.au
www.mims.com.au